CHOKSILA

Choksi Laboratories Ltd.

BSE: 526546

Sector: Healthcare

Industry Group: Healthcare Services

Industry: Healthcare Service Provider

216.90+9.9 (+4.78%)

14 Oct, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

40.9 / 100

Value Score

18.3 / 100

Price Momentum Score

92.8 / 100

QVM Score

47.6 / 100

Key Metrics

Market Cap

151.07

P/E (TTM)

69.89

P/B

5.91

P/S (TTM)

3.23

EV/EBITDA

14.79

CAPE (5Y)

74.15

ROE (TTM)

7.99

ROCE (TTM)

8.97

ROA (TTM)

2.86

Avg 3Y ROE

6.59

Earnings 3Y CAGR

-13.11

Sales 3Y CAGR

10.15

Sales 5Y CAGR

12.31

Debt/Equity

1.34

Consensus TP

Strong Buy %

Promoter Holding

31.48

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Choksi Laboratories Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong price momentum

Price Momentum score of 92.8 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

92.8 / 100

Strong EPS growth and above median growth of industry

The company delivered strong EPS growth of 44.45% for 12-month ended 30 Jun 2026 and the growth was 22.97 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Company's earnings are of high quality

Earnings quality score of 73.0 indicates that the company's earnings are of high quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

73.0 / 100

Negative

Expensive and at a premium to industry median P/E

PE TTM of 69.89 indicates that the stock is expensive on a standalone basis and is at a 221.04% premium to industry median P/E

What is P/E Ratio?

Median: 21.77

Value 69.89

5.29364.2

Low but stable ROE

The company reported low ROE of 7.99% for 12-month ended 30 Jun 2026 and ROE improved marginally by 134 bps from 1 year ago

What is ROE (FY)?

Moderate revenue growth but lower than median growth of industry

The company delivered moderate revenue growth of 10.73% for 12-month ended 30 Jun 2026 but the growth was 3.84 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 14.57

Value 10.73

-93.87133.74

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Moderate and stable operating margin

The company reported moderate operating margin of 10.91% for 12-month ended 30 Jun 2026 and operating margin declined marginally by -3 bps from 1 year ago

What is Operating profit margin?

Reasonable Debt to Equity, and has been stable

The company has reasonable Debt to Equity of 1.34 as on 30 Jun 2026 and Debt to Equity increased marginally by 0.1 in the last 1 year

What is Debt to Equity?

Financial Snapshot

See detailed analysis

Multi-year trends for Choksi Laboratories Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Choksi Laboratories Ltd. Shareholding Pattern

Quarterly breakdown of Choksi Laboratories Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Total Promoter	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48
Indian Promoter	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48	31.48
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.94	4.31	5.69	5.69	6.03	7.02	10.01
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.94	4.31	5.69	5.69	6.03	7.02	10.01
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	68.52	68.52	68.52	68.52	68.52	68.52	68.52	68.52	68.52	68.52	68.52	68.52	68.52	68.52	68.52	68.52	68.52	68.52	68.52	68.52	66.58	64.21	62.83	62.83	62.49	61.50	58.51
Bodies Corporate	3.11	3.09	3.08	2.96	2.18	3.98	3.97	4.18	4.10	4.18	4.74	4.52	4.55	4.54	4.64	5.08	4.58	4.38	4.02	4.37	10.61	12.50	12.16	11.91	10.89	9.88	7.90
Others (incl. Retail) No. of shareholders	65.41 3,472	65.43 3,482	65.44 3,464	65.56 3,446	66.34 3,416	64.54 3,440	64.55 3,473	64.34 3,501	64.42 3,516	64.34 3,534	63.78 3,493	64.00 3,486	63.97 3,502	63.98 3,551	63.88 3,742	63.44 3,868	63.94 4,147	64.14 4,016	64.50 4,294	64.15 4,427	55.97 4,121	51.71 4,126	50.67 4,033	50.92 4,024	51.60 3,979	51.62 3,914	50.61 3,793

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

Choksi Laboratories Ltd. is not part of any tracked index.

Prominent Investor Holdings

Dheeraj Kumar Lohia and Associates

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Choksi Laboratories Ltd. shares as reported to NSE and BSE.

Name	Date	Type	Price	Qty.	Value
Emkay Commercial Company Limited	03 Sep 2026	buy	₹ 165.00	39.76 k	-
Nexus Global Opportunities Fund	31 Aug 2026	buy	₹ 144.25	1.61 lac	-
Emkay Commercial Company Limited	31 Aug 2026	sell	₹ 144.25	1.18 lac	-
Asc Consulting Private Limited	31 Aug 2026	sell	₹ 144.25	43.27 k	-
M7 Global Fund Pcc - Cell Vertex	26 Aug 2026	buy	₹ 145.60	40.00 k	-
Emkay Commercial Company Limited	26 Aug 2026	sell	₹ 145.60	40.00 k	-
Nexus Global Opportunities Fund	19 May 2026	buy	₹ 103.05	68.73 k	-
Csg Financial & Management Services Private Limited	19 May 2026	sell	₹ 103.06	70.00 k	-
Essence Dealmark Private Limited	06 Nov 2025	sell	₹ 142.28	40.46 k	-
Nexus Global Opportunities Fund	13 Aug 2025	buy	₹ 215.00	50.00 k	₹ 1.07 cr

…

No corporate action data available.

Company Profile

Overview of Choksi Laboratories Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Choksi Laboratories Limited is an India-based provider of contract testing and analytical services. The Company analyzes, for its clients, or as a regulatory requirement, pharmaceuticals, food and agricultural products, construction materials, chemicals, calibration and environmental monitoring serv...

Key personnel

Mr. Prakhar Dubey

Compliance Officer, Company Secretary

Mr. Sunil Kumar ChoksiD

Executive Chairman of the Board, Managing Director

Mrs. Stela ChoksiD

Chief Financial Officer, Whole Time Director

Ms. Himika ChoksiD

Whole Time Director

Mr. Vyangesh ChoksiD

Whole Time Director

Mrs. Prachi MantriD

Non-Executive Independent Director

Mr. Ritik PavechaD

Additional Non-Executive Independent Director

Mrs. Abha ShastriD

Non-Executive Independent Director

View all

Incorporated on

29 Jan 1993

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

364

IPO date

13 Jun 1994

Free Float

27,30,219

Website

http://www.choksilab.com/

Phone no.

+917313501112

Address

SURVEY NO 9/1, NEAR TULSIYANA INDUSTRIAL PARK, GRAM KUMERDI, , 452010, India

Frequently Asked Questions

What is the current share price of Choksi Laboratories Ltd.?

The current share price of Choksi Laboratories Ltd. is ₹ 216.90 as of 14 Oct 2026.

What is the market capitalisation of Choksi Laboratories Ltd.?

The market capitalisation of Choksi Laboratories Ltd. stands at ₹ 151.07 Cr.

What is the PE ratio of Choksi Laboratories Ltd.?

The Price-to-Earnings (PE) ratio of Choksi Laboratories Ltd. is 69.89 as of the latest trailing twelve months data.

What is the ROE and ROCE of Choksi Laboratories Ltd.?

Choksi Laboratories Ltd. has a Return on Equity (ROE) of 7.99% and a Return on Capital Employed (ROCE) of 8.97% as per the latest financial reports.

What is the 52-week high and low of Choksi Laboratories Ltd.?

The 52-week high of Choksi Laboratories Ltd. is - and the 52-week low is -.

What is the dividend yield of Choksi Laboratories Ltd.?

The dividend yield of Choksi Laboratories Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Choksi Laboratories Ltd.?

Foreign Institutional Investors (FII) hold 10.01%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 50.61% of Choksi Laboratories Ltd. shares.

What sector does Choksi Laboratories Ltd. belong to?

Choksi Laboratories Ltd. operates in the Healthcare sector.

What is the beta of Choksi Laboratories Ltd.?

The beta of Choksi Laboratories Ltd. is 0.46, indicating its price volatility relative to the broader market. Over the past 1 year, Choksi Laboratories Ltd. has delivered an absolute return of 22.85%.

What is the RSI of Choksi Laboratories Ltd.?

The 14-day Relative Strength Index (RSI) of Choksi Laboratories Ltd. is 70.78, placing it in the overbought zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Choksi Laboratories Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Choksi Laboratories Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Company Profile

Frequently Asked Questions

Company Profile

Holdings and Presence

Stock Analysis